These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38741602)

  • 1. From apparent pseudoprogression to durable complete remission of expansile destructive sinonasal mucosal melanoma under pembrolizumab after primary endoscopic resection: A case report.
    Lu HC; Shen PH; Kok VC
    SAGE Open Med Case Rep; 2024; 12():2050313X241253471. PubMed ID: 38741602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudoprogression with subsequent complete response and severe thrombocytopenia to checkpoint inhibitor immunotherapy in a patient with advanced mucosal melanoma of the sinonasal cavity.
    Philipp M; Frischhut N; Tschachler A; Steinkohl F; Weinlich G; Schmuth M; Nguyen VA
    Anticancer Drugs; 2018 Oct; 29(9):914-918. PubMed ID: 29952773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Malignant Melanoma of the Gastroesophageal Junction Treated With Immunotherapy: A Case Report.
    Attlassy N; Agbeh A; Patnaik R; Miller J; McCarthy J
    WMJ; 2023 Mar; 122(1):77-80. PubMed ID: 36940130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant mucosal melanoma of paranasal sinuses: A case report.
    Kieu HD; Le TD; Nguyen V; Tran TQ
    Int J Surg Case Rep; 2021 Oct; 87():106450. PubMed ID: 34592516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report.
    Lepir T; Zaghouani M; Roche SP; Li YY; Suarez M; Irias MJ; Savaraj N
    Medicine (Baltimore); 2019 Jan; 98(2):e13804. PubMed ID: 30633154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelanotic Malignant Mucosal Melanoma of the Nasal Cavity: Case Report and Literature Review.
    Tahiri I; El Houari O; Hajjij A; Zalagh M; Benariba F
    Cureus; 2022 Feb; 14(2):e22442. PubMed ID: 35371814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report.
    Gonugunta AS; von Itzstein MS; Gerber DE
    J Med Case Rep; 2022 Jul; 16(1):289. PubMed ID: 35871685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial.
    Ahmed FS; Dercle L; Goldmacher GV; Yang H; Connors D; Tang Y; Karovic S; Zhao B; Carvajal RD; Robert C; Maitland ML; Oxnard GR; Schwartz LH
    Eur Radiol; 2021 Apr; 31(4):1853-1862. PubMed ID: 32995974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoprogression of Metastatic Melanoma to the Orbit With Pembrolizumab.
    Garcia GA; Topping KL; Mruthyunjaya P; Kossler AL
    Ophthalmic Plast Reconstr Surg; 2020; 36(2):e36-e40. PubMed ID: 32134764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudoprogression presenting as intestinal perforation in non-small cell lung cancer treated with anti-PD-1: A case report.
    Kim HK; Baek SW; Jeong Y; Yang Y; Kwon J; Han HS; An JY; Woo CG; Lee OJ; Lee TG; Lee KH
    Mol Clin Oncol; 2019 Aug; 11(2):132-134. PubMed ID: 31281646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Treatment of Sinonasal Mucosal Melanoma in Patients Treated with Systemic Immunotherapy.
    Chao TN; Kuan EC; Tong CCL; Kohanski MA; Grady MS; Palmer JN; Adappa ND; O'Malley BW
    J Neurol Surg B Skull Base; 2021 Jul; 82(Suppl 3):e148-e154. PubMed ID: 34306930
    [No Abstract]   [Full Text] [Related]  

  • 12. Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma.
    Robert C; Ribas A; Hamid O; Daud A; Wolchok JD; Joshua AM; Hwu WJ; Weber JS; Gangadhar TC; Joseph RW; Dronca R; Patnaik A; Zarour H; Kefford R; Hersey P; Zhang J; Anderson J; Diede SJ; Ebbinghaus S; Hodi FS
    J Clin Oncol; 2018 Jun; 36(17):1668-1674. PubMed ID: 29283791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer with brain metastases remaining in continuous complete remission due to pembrolizumab and temozolomide: a case report.
    Zhu X; Dong S; Tang J; Xie R; Wu H; Hofman P; Mrugala MM; Hu S
    Ann Transl Med; 2022 Sep; 10(17):942. PubMed ID: 36172106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of a patient with advanced mucosal malignant melanoma in the sinonasal area.
    Fusetti M; Eibenstein A; Lupi E; Iacomino E; Pieramici T; Fioretti A
    Ear Nose Throat J; 2014 Jan; 93(1):E1-5. PubMed ID: 24452895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy.
    Alexander GS; Palmer JD; Tuluc M; Lin J; Dicker AP; Bar-Ad V; Harshyne LA; Louie J; Shaw CM; Hooper DC; Lu B
    J Hematol Oncol; 2016 Sep; 9(1):96. PubMed ID: 27663515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission.
    Satish T; Khan S; Levin M; Carvajal R; Yoon AJ
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34716205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution in Sinonasal Mucosal Melanoma Management.
    Richa T; Lee A; Cohen MA
    J Neurol Surg Rep; 2022 Jan; 83(1):e1-e2. PubMed ID: 35028276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma.
    Moya-Plana A; Herrera Gómez RG; Rossoni C; Dercle L; Ammari S; Girault I; Roy S; Scoazec JY; Vagner S; Janot F; Eggermont AMM; Robert C
    Cancer Immunol Immunother; 2019 Jul; 68(7):1171-1178. PubMed ID: 31172258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review.
    Kim MS; Choi CH; Kim TJ; Lee JW; Lee J; Bae DS; Kim BG
    Obstet Gynecol Sci; 2018 Jul; 61(4):524-528. PubMed ID: 30018908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-Immunotherapy Robotic-Assisted Resection for Primary Anorectal Melanoma: A Case Report.
    Tsutsui K; Ogata D; Tsukamoto S; Moritani K; Mori T; Namikawa K; Takahashi A; Kanemitsu Y; Yamazaki N
    Case Rep Oncol; 2022; 15(1):56-61. PubMed ID: 35350812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.